BackEssa Pharma Overview

Essa Pharma Receivables

Essa Pharma's receivables is $530K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$527148.00
↑ 187.14% YoYΔ $343563.00 vs prior year quarter

Peer trimmed avg / median

Loading

Essa Pharma Receivables History

Loading

Essa Pharma vs. peers: Receivables Comparison

Loading

Essa Pharma Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Essa Pharma (EPIX) FAQ

As of the most recent data (June 2025), EPIX shows a receivables of $530K. That compares with $180K in the prior-year period — up 187.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EPIX's receivables is now $530K (was $180K) — a 187.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Essa Pharma is outperforming or lagging.

Tracking EPIX's receivables over time shows whether Essa Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $530K That compares with $180K in the prior-year period — up 187.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Essa Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $530K) with ownership activity and broader fundamentals.

Essa Pharma's receivables is $530K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.